PP4C facilitates lung cancer proliferation and inhibits apoptosis via activating MAPK/ERK pathway

Bin Wang; Xunxia Zhu; Linyue Pan; Hefeng Chen; Xiaoyong Shen

doi:10.1016/j.prp.2020.152910

ScienceGate Book Chapters

JOURNAL ARTICLE

PP4C facilitates lung cancer proliferation and inhibits apoptosis via activating MAPK/ERK pathway

Bin Wang Xunxia Zhu Linyue Pan Hefeng Chen Xiaoyong Shen

Year: 2020 Journal: Pathology - Research and Practice Vol: 216 (5)Pages: 152910-152910 Publisher: Elsevier BV

DOI: 10.1016/j.prp.2020.152910

Get Full-Text PDF Get Analytical Report

Keywords:

Carcinogenesis Lung cancer Cancer research Cell growth Flow cytometry MAPK/ERK pathway Downregulation and upregulation Apoptosis Cancer Biology Western blot Kinase Medicine Pathology Molecular biology Cell biology Biochemistry

Metrics

Cited By

1.56

FWCI (Field Weighted Citation Impact)

Refs

0.80

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Protein Tyrosine Phosphatases

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

Melanoma and MAPK Pathways

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

interferon and immune responses

Life Sciences → Immunology and Microbiology → Immunology

PP4C facilitates lung cancer proliferation and inhibits apoptosis via activating MAPK/ERK pathway

Metrics

Citation History

Topics

Related Documents

Targeting HSP90 Inhibits Proliferation and Induces Apoptosis Through AKT1/ERK Pathway in Lung Cancer

Vanillin oxime inhibits lung cancer cell proliferation and activates apoptosis through JNK/ERK-CHOP pathway

Butyrate promotes C2C12 myoblast proliferation by activating ERK/MAPK pathway

SLC25A22 promotes proliferation and metastasis by activating MAPK/ERK pathway in gallbladder cancer

ATX‑LPA axis facilitates estrogen‑induced endometrial cancer cell proliferation via MAPK/ERK signaling pathway